Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

ZHANG Su-jiang, LIN Lu. The effect of valsartan on patients with hypertension and non-alcoholic fatty liver disease[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(4): 299-301.
Citation: ZHANG Su-jiang, LIN Lu. The effect of valsartan on patients with hypertension and non-alcoholic fatty liver disease[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(4): 299-301.

The effect of valsartan on patients with hypertension and non-alcoholic fatty liver disease

  • Received Date: 2012-04-21
  • Rev Recd Date: 2012-05-29
  • Objective To explore the effect of valsartan on patients with hypertension and non-alcoholic fatty liver disease (NAFLD),Methods A total of 148 patients suffered hypertension and NAFLD were included in the study. Patients were divided into the observed group the compared group.which were given valsartan and analodipine respectively. The difference of the blood pressure,liver ultrasound,liver function,serum lipids,insulin resistance index (RI) and clinical curative effect were compared between the two groups. Results The curative effect in the observed group (93.24%) was significantly higher than that in the compared group (81.08%);After treatment,the alanine aminolransferase,cholesterol,triglyceride,low density lipoprotein and RI in the observed group were significantly lower than that in the compared group (P<0.05). Conclusion The valsartan had a good effect on patients suffered hypertension and NAFLD.
  • 加载中
通讯作者: 陈斌, [email protected]
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2870) PDF downloads(601) Cited by()

Related
Proportional views

The effect of valsartan on patients with hypertension and non-alcoholic fatty liver disease

Abstract: Objective To explore the effect of valsartan on patients with hypertension and non-alcoholic fatty liver disease (NAFLD),Methods A total of 148 patients suffered hypertension and NAFLD were included in the study. Patients were divided into the observed group the compared group.which were given valsartan and analodipine respectively. The difference of the blood pressure,liver ultrasound,liver function,serum lipids,insulin resistance index (RI) and clinical curative effect were compared between the two groups. Results The curative effect in the observed group (93.24%) was significantly higher than that in the compared group (81.08%);After treatment,the alanine aminolransferase,cholesterol,triglyceride,low density lipoprotein and RI in the observed group were significantly lower than that in the compared group (P<0.05). Conclusion The valsartan had a good effect on patients suffered hypertension and NAFLD.

ZHANG Su-jiang, LIN Lu. The effect of valsartan on patients with hypertension and non-alcoholic fatty liver disease[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(4): 299-301.
Citation: ZHANG Su-jiang, LIN Lu. The effect of valsartan on patients with hypertension and non-alcoholic fatty liver disease[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(4): 299-301.

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return